MX9805099A - Aminoguanidina para tratamiento de diabetes mellitus no dependiente de insulina. - Google Patents

Aminoguanidina para tratamiento de diabetes mellitus no dependiente de insulina.

Info

Publication number
MX9805099A
MX9805099A MX9805099A MX9805099A MX9805099A MX 9805099 A MX9805099 A MX 9805099A MX 9805099 A MX9805099 A MX 9805099A MX 9805099 A MX9805099 A MX 9805099A MX 9805099 A MX9805099 A MX 9805099A
Authority
MX
Mexico
Prior art keywords
aminoguanidine
diabetes
type
treating niddm
human
Prior art date
Application number
MX9805099A
Other languages
English (en)
Inventor
Nicholas Charles Turner
Valerie Piercy
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9526330.7A external-priority patent/GB9526330D0/en
Priority claimed from GBGB9624914.9A external-priority patent/GB9624914D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MX9805099A publication Critical patent/MX9805099A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processing Of Solid Wastes (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se describe un método para el tratamiento y/o profilaxis de diabetes de tipo II, dicho método comprendiendo la administracion, a un ser humano o aun mamífero no humano, de una cantidad farmacéuticamente aceptable, no toxica, efectiva, de un inhibidor de glicacion de proteína, tal como aminoguanidina; preferiblemente; la invencion provee un método para el tratamiento profiláctico de diabetes de tipo II, en particular demorando o evitando el progreso de hiperinsulina a hiperglicemia.
MX9805099A 1995-12-22 1998-06-22 Aminoguanidina para tratamiento de diabetes mellitus no dependiente de insulina. MX9805099A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9526330.7A GB9526330D0 (en) 1995-12-22 1995-12-22 Novel method
GBGB9624914.9A GB9624914D0 (en) 1996-11-29 1996-11-29 Novel method

Publications (1)

Publication Number Publication Date
MX9805099A true MX9805099A (es) 1998-10-31

Family

ID=26308373

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9805099A MX9805099A (es) 1995-12-22 1998-06-22 Aminoguanidina para tratamiento de diabetes mellitus no dependiente de insulina.

Country Status (18)

Country Link
EP (1) EP0868176B1 (es)
JP (1) JP2000502667A (es)
KR (1) KR19990076594A (es)
CN (1) CN1209058A (es)
AT (1) ATE369847T1 (es)
AU (1) AU1307697A (es)
BR (1) BR9612250A (es)
CA (1) CA2240492A1 (es)
CZ (1) CZ198798A3 (es)
DE (1) DE69637209T2 (es)
ES (1) ES2292176T3 (es)
HU (1) HUP9903978A3 (es)
IL (1) IL124869A0 (es)
MX (1) MX9805099A (es)
NO (1) NO982853L (es)
PL (1) PL327471A1 (es)
TR (1) TR199801120T2 (es)
WO (1) WO1997023203A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20020625A1 (it) * 2002-12-17 2004-06-18 Sigma Tau Ind Farmaceuti Derivati di guanidine variamente sostituite, loro uso come medicamenti ad attivita' antidiabetica e/o antiobesita'.
CN100411615C (zh) * 2003-12-12 2008-08-20 上海第二医科大学附属瑞金医院 氨基胍对难愈创面的防治作用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665192A (en) * 1984-03-19 1987-05-12 The Rockefeller University 2-(2-furoyl)-4(5)-2(furanyl)-1H-imidazole
WO1991012799A1 (en) * 1990-02-28 1991-09-05 The Upjohn Company Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
AU3876995A (en) * 1994-11-17 1996-06-17 McDougall, Greg Electric fan heater

Also Published As

Publication number Publication date
JP2000502667A (ja) 2000-03-07
AU1307697A (en) 1997-07-17
BR9612250A (pt) 1999-07-13
NO982853D0 (no) 1998-06-19
ES2292176T3 (es) 2008-03-01
CN1209058A (zh) 1999-02-24
PL327471A1 (en) 1998-12-07
CA2240492A1 (en) 1997-07-03
DE69637209D1 (de) 2007-09-27
WO1997023203A1 (en) 1997-07-03
EP0868176B1 (en) 2007-08-15
CZ198798A3 (cs) 1999-06-16
ATE369847T1 (de) 2007-09-15
DE69637209T2 (de) 2008-05-08
IL124869A0 (en) 1999-01-26
HUP9903978A2 (hu) 2000-03-28
HUP9903978A3 (en) 2001-01-29
EP0868176A1 (en) 1998-10-07
NO982853L (no) 1998-06-19
KR19990076594A (ko) 1999-10-15
TR199801120T2 (xx) 1998-09-21

Similar Documents

Publication Publication Date Title
GB2288732B (en) Pharmaceutical compositions
NO982311L (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt
PL338705A1 (en) Application of gaba analogues in preventing and treating gastrointestinal diseases
NZ504432A (en) Use of lysophosphatidylethanolamine (18:1) and lysophosphatidylinositol to retard senescene and to enhance fruit ripening
IL187254A (en) ANTISENSE NUCLEOTIDES, COMPOSITIONS COMPRISING THEREOF AND THEIR USE IN MODULATING ACTIVATION OF NF-kB
UA32568C2 (uk) Спосіб обдирання зерна, спосіб обдирання та підготовки зерна до розмелювання, пристрій для обдирання зерна і пристрій для обдирання та підготовки зерна до розмелювання
AU7500794A (en) Novel use of dexmedetomidine
IL136299A0 (en) Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
BG102797A (en) The carboznhydrase inhibitor application for the treatment of the maculate oedema
WO1998032428A3 (en) Compositions comprising choline and use of choline to treat endotoxic shock
IL124869A0 (en) Aminoguanidine for treating niddm
EP0744176A3 (en) Methods for inhibiting bone loss
YU45103A (sh) Upotreba sarp/1 za lečenje i prevenciju skleroderme
AU7941294A (en) Composition for the treatment or prevention of herpes
IL124870A0 (en) Nitric oxide (no) synthase inhibitor to treat or prevent type ii diabetes
EP0974351A3 (en) Medicament for preventing and treating gastrointestinal damage
AU6502194A (en) Oestriol-containing hormonal agent for the prophylaxis and treatment of arterial conditions in humans, method of preparing it and its use
CA2233677A1 (en) A novel combination of a .beta.-receptor blocker and an opioid
MD1296F1 (en) The Nicolau method of treatment of the lichen planus
EP0663211A4 (en) AGENT FOR PREVENTION AND TREATMENT OF DIGESTIVE APPARATUS MUCOUS DISORDERS.
BG102974A (en) Ethene-containing solutions and their use in methods of treatment or prevention